{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:22:33Z","timestamp":1764782553572,"version":"3.46.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"DOI":"10.7759\/cureus.98390","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:11:33Z","timestamp":1764781893000},"source":"Crossref","is-referenced-by-count":0,"title":["Sarcoidosis Mimicking Metastatic Disease: Multisystem Involvement With Osseous Manifestations"],"prefix":"10.7759","author":[{"given":"Filipa","family":"Canedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria In\u00eas","family":"Carvalhinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Borba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman RP","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P, et al.. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021, 58:2004079. 10.1183\/13993003.04079-2020","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser ED","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, et al.. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020, 201:e26-51. 10.1164\/rccm.202002-0251ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex317","article-title":"A review of the musculoskeletal manifestations of sarcoidosis","volume":"57","author":"Bechman K","year":"2018","unstructured":"Bechman K, Christidis D, Walsh S, Birring SS, Galloway J. A review of the musculoskeletal manifestations of sarcoidosis. Rheumatology (Oxford). 2018, 57:777-83. 10.1093\/rheumatology\/kex317","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.02.004","article-title":"Clinical characteristics of patients with bone sarcoidosis","volume":"47","author":"Zhou Y","year":"2017","unstructured":"Zhou Y, Lower EE, Li H, Farhey Y, Baughman RP. Clinical characteristics of patients with bone sarcoidosis. Semin Arthritis Rheum. 2017, 47:143-8. 10.1016\/j.semarthrit.2017.02.004","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3182335f9b","article-title":"F-18 FDG PET\/CT for detecting bone and bone marrow involvement in sarcoidosis patients","volume":"37","author":"Mostard RL","year":"2012","unstructured":"Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, Drent M. F-18 FDG PET\/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med. 2012, 37:21-5. 10.1097\/RLU.0b013e3182335f9b","journal-title":"Clin Nucl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071866","article-title":"Imaging plays a key role in the diagnosis and control of the treatment of bone sarcoidosis","volume":"11","author":"B\u0142asi\u0144ska K","year":"2023","unstructured":"B\u0142asi\u0144ska K, J\u0119drych ME, Opoka L, Tomkowski W, Szturmowicz M. Imaging plays a key role in the diagnosis and control of the treatment of bone sarcoidosis. Biomedicines. 2023, 11:1866. 10.3390\/biomedicines11071866","journal-title":"Biomedicines"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2024.11.010","article-title":"Osseous sarcoidosis presenting as lytic and blastic bone lesions: a rare diagnostic challenge","volume":"20","author":"Bastidas J","year":"2025","unstructured":"Bastidas J, L\u00f3pez-Nu\u00f1ez L, Far\u00e9 R, Mor\u00ed\u00f1igo JG, Ros I, Mas AJ. Osseous sarcoidosis presenting as lytic and blastic bone lesions: a rare diagnostic challenge. Radiol Case Rep. 2025, 20:1247-51. 10.1016\/j.radcr.2024.11.010","journal-title":"Radiol Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2024.102077","article-title":"Evaluation of sarcoidosis with multiple bone lesions using both bone scintigraphy and FDG-PET\/CT: a case report","volume":"51","author":"Kadoma N","year":"2024","unstructured":"Kadoma N, Atsumi K, Shinbu K, et al.. Evaluation of sarcoidosis with multiple bone lesions using both bone scintigraphy and FDG-PET\/CT: a case report. Respir Med Case Rep. 2024, 51:102077. 10.1016\/j.rmcr.2024.102077","journal-title":"Respir Med Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30033-9","article-title":"Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study","volume":"4","author":"Walsh SL","year":"2016","unstructured":"Walsh SL, Wells AU, Desai SR, et al.. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016, 4:557-65. 10.1016\/S2213-2600(16)30033-9","journal-title":"Lancet Respir Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.545413","article-title":"Treatment of sarcoidosis: a multidisciplinary approach","volume":"11","author":"Gerke AK","year":"2020","unstructured":"Gerke AK. Treatment of sarcoidosis: a multidisciplinary approach. Front Immunol. 2020, 11:545413. 10.3389\/fimmu.2020.545413","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000720","article-title":"Current treatment of sarcoidosis","volume":"26","author":"Sellar\u00e9s J","year":"2020","unstructured":"Sellar\u00e9s J, Francesqui J, Llabres M, Hernandez-Gonzalez F, Baughman RP. Current treatment of sarcoidosis. Curr Opin Pulm Med. 2020, 26:591-7. 10.1097\/MCP.0000000000000720","journal-title":"Curr Opin Pulm Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2015.537","article-title":"Sarcoidosis with bone involvement mimicking metastatic disease at 18F-FDG PET\/CT: problem solving by diffusion whole-body MRI","volume":"9","author":"Conte G","year":"2015","unstructured":"Conte G, Zugni F, Colleoni M, Renne G, Bellomi M, Petralia G. Sarcoidosis with bone involvement mimicking metastatic disease at 18F-FDG PET\/CT: problem solving by diffusion whole-body MRI. Ecancermedicalscience. 2015, 9:537. 10.3332\/ecancer.2015.537","journal-title":"Ecancermedicalscience"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2021.06.008","article-title":"Limitations and Pitfalls of FDG-PET\/CT in Infection and Inflammation","volume":"51","author":"Pijl JP","year":"2021","unstructured":"Pijl JP, Nienhuis PH, Kwee TC, Glaudemans AW, Slart RH, Gormsen LC. Limitations and Pitfalls of FDG-PET\/CT in Infection and Inflammation. Semin Nucl Med. 2021, 51:633-45. 10.1053\/j.semnuclmed.2021.06.008","journal-title":"Semin Nucl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2017.02.004","article-title":"Benign bone conditions that may be FDG-avid and mimic malignancy","volume":"47","author":"Kwee TC","year":"2017","unstructured":"Kwee TC, de Klerk JM, Nix M, Heggelman BG, Dubois SV, Adams HJ. Benign bone conditions that may be FDG-avid and mimic malignancy. Semin Nucl Med. 2017, 47:322-51. 10.1053\/j.semnuclmed.2017.02.004","journal-title":"Semin Nucl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152654","article-title":"Axial bone involvement in sarcoidosis has a good prognosis: longitudinal study of a cohort of 48 patients","volume":"71","author":"Challal S","year":"2025","unstructured":"Challal S, Riviere E, Lanseur B, et al.. Axial bone involvement in sarcoidosis has a good prognosis: longitudinal study of a cohort of 48 patients. Semin Arthritis Rheum. 2025, 71:152654. 10.1016\/j.semarthrit.2025.152654","journal-title":"Semin Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1017501","article-title":"Diagnosing interstitial lung disease by multidisciplinary discussion: a review","volume":"9","author":"Glenn LM","year":"2022","unstructured":"Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: a review. Front Med (Lausanne). 2022, 9:1017501. 10.3389\/fmed.2022.1017501","journal-title":"Front Med (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal DG","year":"2019","unstructured":"Rosenthal DG, Parwani P, Murray TO, et al.. Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis. J Am Heart Assoc. 2019, 8:e010952. 10.1161\/JAHA.118.010952","journal-title":"J Am Heart Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-022-03171-6","article-title":"Prednisone vs methotrexate in treatment na\u00efve cardiac sarcoidosis","volume":"30","author":"Vis R","year":"2023","unstructured":"Vis R, Mathijssen H, Keijsers RG, et al.. Prednisone vs methotrexate in treatment na\u00efve cardiac sarcoidosis. J Nucl Cardiol. 2023, 30:1543-53. 10.1007\/s12350-022-03171-6","journal-title":"J Nucl Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.950095","article-title":"Re-evaluating serum angiotensin-converting enzyme in sarcoidosis","volume":"14","author":"Zheng SY","year":"2023","unstructured":"Zheng SY, Du X, Dong JZ. Re-evaluating serum angiotensin-converting enzyme in sarcoidosis. Front Immunol. 2023, 14:950095. 10.3389\/fimmu.2023.950095","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger R","year":"2020","unstructured":"Kraaijvanger R, Janssen Bon\u00e1s M, Vorselaars AD, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020, 11:1443. 10.3389\/fimmu.2020.01443","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437597-sarcoidosis-mimicking-metastatic-disease-multisystem-involvement-with-osseous-manifestations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:11:33Z","timestamp":1764781893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437597-sarcoidosis-mimicking-metastatic-disease-multisystem-involvement-with-osseous-manifestations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.98390","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}